a public good project by the
Synthesis
Company
of California

© 2026

Willem A. Hanekom | doi.page

0 works0 citations0 h-index

Willem A. Hanekom

Africa Health Research Institute(ZA)University College London(GB)

Publications by Year

Research Areas

Tuberculosis Research and Epidemiology, Immunodeficiency and Autoimmune Disorders, Immune responses and vaccinations, Mycobacterium research and diagnosis, Immune Cell Function and Interaction

Most-Cited Works

→ Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization(2021)1,178 cited
→ Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial(2013)1,026 cited
→ A blood RNA signature for tuberculosis disease risk: a prospective cohort study(2016)806 cited
→ Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma(2021)706 cited
→ Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination(2018)656 cited
→ Immunological biomarkers of tuberculosis(2011)475 cited

→ Specific T Cell Frequency and Cytokine Expression Profile Do Not Correlate with Protection against Tuberculosis after Bacillus Calmette-Guérin Vaccination of Newborns(2010)

404 cited

→ Distinct, Specific IL-17- and IL-22-Producing CD4+ T Cell Subsets Contribute to the Human Anti-Mycobacterial Immune Response(2008)404 cited

→ Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease(2011)390 cited

→ SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection(2021)361 cited